Tri-modality Therapy in Esophageal Carcinoma is at a Crossroad

Ann Surg Oncol. 2025 Feb;32(2):643-645. doi: 10.1245/s10434-024-16499-9. Epub 2024 Nov 15.

Authors

Yogesh K Vashist¹, Srijan Shukla², Ehab Abufarhaneh³, Dieter C Broering³, Thammineedi Subramanyeshwar Rao²

Affiliations

¹ Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia. [email protected].
² Department of Surgical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India.
³ Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.

PMID: 39548052
DOI: 10.1245/s10434-024-16499-9

No abstract available

Publication types

Editorial